Financhill
Back

Becton Dickinson & Vs. 4D Molecular Therapeutics Industry Stock Comparison

Sell
45

BDX
Becton Dickinson &

Last Price:
231.64
Seasonality Move:
0.61%
Sell
16

FDMT
4D Molecular Therapeutics

Last Price:
23.21
Seasonality Move:
-20.46%
Sell
45
Becton Dickinson & (BDX) is a Sell

Is Becton Dickinson & a Buy, Sell or Hold?

  • The current Becton Dickinson & [BDX] share price is $231.55. The Score for BDX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDX Stock Price Chart

What is Becton Dickinson &'s stock price today?

  • The Becton Dickinson & share price today is $231.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDX is experiencing slight selling pressure.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $23.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.

BDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.41 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -13413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (233.43 - 244.59) Sell
Bollinger Bands (100): (234.8 - 242.94) Sell

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: -30640 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.57 - 31.31) Sell
Bollinger Bands (100): (18.43 - 29.93) Sell

BDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 232.95 Sell
20-day SMA: 237.57 Sell
50-day SMA: 239.09 Sell
200-day SMA: 250.43 Sell
8-day EMA: 233.24 Sell
20-day EMA: 236 Sell
50-day EMA: 238.26 Sell
200-day EMA: 244.82 Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.7 Sell
20-day SMA: 26.48 Sell
50-day SMA: 28.52 Sell
200-day SMA: 19.19 Buy
8-day EMA: 24.68 Sell
20-day EMA: 26.35 Sell
50-day EMA: 26.76 Sell
200-day EMA: 21.52 Buy

Becton Dickinson & Earnings Growth & BDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.38 per share, an increase this year of $0.81 per share, and an increase next year of $1.37 per share.

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.

Becton Dickinson & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):